| RS1555874555 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS1555874726 |
SPECC1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Teebi hypertelorism syndrome, Teebi hypertelorism syndrome 1 |
| RS1555874803 |
CBS
|
Health Risk |
Pathogenic/Likely pathogenic |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS1555874874 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Homocystinuria |
| RS1555875292 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS1555875308 |
SMARCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Intellectual disability |
| RS1555875325 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, CBS-related disorder |
| RS1555875358 |
RSPH1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1555875387 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS1555875892 |
SMARCB1
|
Health Risk |
Pathogenic |
— |
| RS1555875915 |
SMARCB1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555875917 |
SMARCB1
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 1, Rhabdoid tumor predisposition syndrome 1 |
| RS1555876140 |
SMARCB1
|
Health Risk |
Pathogenic |
Teratoid tumor, atypical |
| RS1555876283 |
PIGT
|
Health Risk |
risk factor |
Paroxysmal nocturnal hemoglobinuria 2, Paroxysmal nocturnal hemoglobinuria 2 |
| RS1555876755 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS1555876784 |
CBS
|
Health Risk |
Pathogenic/Likely pathogenic |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS1555877107 |
COL18A1
|
Health Risk |
Pathogenic |
Knobloch syndrome, Knobloch syndrome |
| RS1555877252 |
COL6A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Collagen 6-related myopathy |
| RS1555877258 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1555877276 |
SMARCB1
|
Health Risk |
Pathogenic |
— |
| RS1555877282 |
COL6A2
|
Health Risk |
Likely pathogenic |
— |
| RS1555877286 |
SMARCB1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Atypical teratoid rhabdoid tumor |
| RS1555877287 |
SMARCB1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 15 |
| RS1555877364 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1555878893 |
CACNA1C
|
Health Risk |
Likely pathogenic |
— |
| RS1555879031 |
CACNA1C
|
Health Risk |
Pathogenic |
— |
| RS1555879360 |
NRIP1
|
Health Risk |
Pathogenic |
Congenital anomaly of kidney and urinary tract, Congenital anomalies of kidney and urinary tract 3 |
| RS1555881112 |
TBX4
|
Health Risk |
Pathogenic |
Coxopodopatellar syndrome, Coxopodopatellar syndrome |
| RS1555881563 |
SMARCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 15 |
| RS1555881567 |
SMARCB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 15 |
| RS1555881586 |
SMARCB1
|
Health Risk |
Pathogenic |
— |
| RS1555881741 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Inborn genetic diseases |
| RS1555881809 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, KCNQ2-related disorder |
| RS1555882009 |
TBX4
|
Health Risk |
Likely pathogenic |
Pulmonary arterial hypertension associated with congenital heart disease, Pulmonary arterial hypertension associated with congenital heart disease |
| RS1555882068 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS1555882291 |
TBX4
|
Health Risk |
Likely pathogenic |
Pulmonary arterial hypertension associated with congenital heart disease, Coxopodopatellar syndrome |
| RS1555882867 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS1555882921 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS1555883338 |
TBX4
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary arterial hypertension associated with congenital heart disease, Pulmonary arterial hypertension associated with congenital heart disease |
| RS1555883342 |
TBX4
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary arterial hypertension associated with congenital heart disease, Pulmonary hypertension |
| RS1555883345 |
EEF1A2
|
Health Risk |
Likely pathogenic |
— |
| RS1555883384 |
EEF1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
EEF1A2-related developmental and degenerative epileptic-dyskinetic encephalopathy, Developmental and epileptic encephalopathy |
| RS1555883466 |
TBX4
|
Health Risk |
Pathogenic |
— |
| RS1555883469 |
TBX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary arterial hypertension associated with congenital heart disease, Pulmonary arterial hypertension associated with congenital heart disease |
| RS1555883486 |
EEF1A2
|
Health Risk |
Likely pathogenic |
— |
| RS1555883501 |
EEF1A2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 33 |
| RS1555883505 |
EEF1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1555883816 |
EEF1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 33 |
| RS1555883860 |
EEF1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 33 |
| RS1555883869 |
EEF1A2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 33 |
| RS1555883949 |
GNAS
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS1555883975 |
EEF1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555884508 |
PI4KA
|
Health Risk |
Likely pathogenic |
— |
| RS1555884790 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1555884845 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1555885023 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS1555885056 |
HLCS
|
Health Risk |
Conflicting classifications of pathogenicity |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS1555887068 |
CACNA1C
|
Health Risk |
Likely pathogenic |
— |
| RS1555888363 |
CSTB
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive myoclonic epilepsy, Unverricht-Lundborg syndrome |
| RS1555888493 |
LOC130066788;CSTB
|
Health Risk |
Likely pathogenic |
— |
| RS1555888762 |
CRYBB2
|
Health Risk |
Likely pathogenic |
Cataract 3 multiple types, Cataract 3 multiple types |
| RS1555889031 |
GNAS
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1555889069 |
KCNB1
|
Health Risk |
Pathogenic |
— |
| RS1555889084 |
KCNB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS1555889090 |
KCNB1
|
Health Risk |
Likely pathogenic |
Epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1555889103 |
KCNB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS1555889108 |
KCNB1
|
Health Risk |
Likely pathogenic |
Epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1555889110 |
KCNB1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1555889114 |
KCNB1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1555889127 |
KCNB1
|
Health Risk |
Likely pathogenic |
6 conditions, Epileptic encephalopathy |
| RS1555889130 |
KCNB1
|
Health Risk |
Pathogenic |
Epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1555889131 |
GNAS
|
Health Risk |
Pathogenic |
Pseudopseudohypoparathyroidism, Inborn genetic diseases |
| RS1555889157 |
KCNB1
|
Health Risk |
Pathogenic |
— |
| RS1555889162 |
KCNB1
|
Health Risk |
Pathogenic |
KCNB1-related disorder, Developmental and epileptic encephalopathy |
| RS1555889308 |
CRYBB2
|
Health Risk |
Likely pathogenic |
Cataract 3 multiple types, Cataract 3 multiple types |
| RS1555889738 |
GSS
|
Health Risk |
Pathogenic |
Inherited glutathione synthetase deficiency, Glutathione synthetase deficiency with 5-oxoprolinuria |
| RS1555889984 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1555890974 |
ACO2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555891562 |
GNAS
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555891584 |
GNAS
|
Health Risk |
Likely pathogenic |
GNAS-related disorder, Pseudohypoparathyroidism type I A |
| RS1555891595 |
GNAS
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, GNAS-related disorder |
| RS1555891728 |
GNAS
|
Health Risk |
Likely pathogenic |
— |
| RS1555891743 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS1555893221 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS1555893359 |
GRIN2D
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 46 |
| RS1555894289 |
CHKB
|
Health Risk |
Likely pathogenic |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS1555894390 |
MID1
|
Health Risk |
Likely pathogenic |
X-linked Opitz G/BBB syndrome, X-linked Opitz G/BBB syndrome |
| RS1555894574 |
TRIOBP
|
Health Risk |
Pathogenic |
— |
| RS1555895066 |
TCN2
|
Health Risk |
Pathogenic |
Transcobalamin II deficiency, Transcobalamin II deficiency |
| RS1555895069 |
TCN2
|
Health Risk |
Likely pathogenic |
— |
| RS1555895466 |
TBX1
|
Health Risk |
Pathogenic |
DiGeorge syndrome, DiGeorge syndrome |
| RS1555895704 |
MID1
|
Health Risk |
Pathogenic |
Dandy-Walker syndrome, X-linked Opitz G/BBB syndrome |
| RS1555895725 |
MID1
|
Health Risk |
Likely pathogenic |
X-linked Opitz G/BBB syndrome, X-linked Opitz G/BBB syndrome |
| RS1555896285 |
TRIOBP
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 28, Autosomal recessive nonsyndromic hearing loss 28 |
| RS1555896474 |
TBX1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555896735 |
SON
|
Health Risk |
Pathogenic |
— |
| RS1555896778 |
GATA5
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS1555896779 |
GATA5
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS1555896814 |
TBX1
|
Health Risk |
Likely pathogenic |
— |
| RS1555896828 |
TBX1
|
Health Risk |
Likely pathogenic |
— |